News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MILLER MICHAEL PATRICK
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 17,000 options to buy
@ $17.52, valued at
$297.8k
|
|
| 06/15/2023 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 13,500 shares
@ $3.4541, valued at
$46.6k
Granted 27,000 shares
@ $0 |
|
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on BioXcel Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $14.27, valued at
$428.1k
|
|
| 07/05/2022 |
3
| MILLER MICHAEL PATRICK (Director) has filed a Form 3 on BioXcel Therapeutics, Inc. |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Sold 25,653 shares
@ $2.7986, valued at
$71.8k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 25,748 shares
@ $0 |
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,500 shares
@ $146.78, valued at
$220.2k
|
|
| 12/10/2019 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 1,500 shares
@ $149.12, valued at
$223.7k
|
|
| 06/12/2019 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 19,423 shares
@ $0 |
|
| 06/07/2019 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 123 shares
@ $130.4, valued at
$16k
|
|
| 03/07/2019 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 833 shares
@ $135.82, valued at
$113.1k
Paid exercise price by delivering 648 shares
@ $135.82, valued at
$88k
|
|
| 03/04/2019 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 8,400 shares
@ $0
Granted 714 options to buy
@ $140.03, valued at
$100k
Granted 20,286 options to buy
@ $140.03, valued at
$2.8M
|
|
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $149.27, valued at
$29.9k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $165.2, valued at
$33k
|
|
| 08/16/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $175.7, valued at
$35.1k
|
|
| 07/17/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $179.15, valued at
$35.8k
|
|
| 06/18/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $176.53, valued at
$35.3k
|
|
| 06/14/2018 |
4
| MILLER MICHAEL PATRICK (Director) has filed a Form 4 on PUMA BIOTECHNOLOGY, INC.|
Txns:
| Granted 5,482 shares
@ $0 |
|
| 06/07/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 123 shares
@ $172.54, valued at
$21.2k
|
|
| 05/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 1,159 shares
@ $147.03, valued at
$170.4k
|
|
| 04/13/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $157.49, valued at
$31.5k
|
|
| 03/16/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 200 shares
@ $151.12, valued at
$30.2k
|
|
| 03/07/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 648 shares
@ $143.39, valued at
$92.9k
|
|
| 03/05/2018 |
4
| MILLER MICHAEL PATRICK (EVP, US Commercial) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 8,000 shares
@ $0
Granted 710 options to buy
@ $140.67, valued at
$99.9k
Granted 19,290 options to buy
@ $140.67, valued at
$2.7M
|
|
|
|
|